文献速递泌尿生殖介入CTMR

前列腺放疗基准标记:0.35毫米与0.5毫米直径CT和磁共振图像比较

Fiducial marker for prostate radiotherapy: comparison of 0.35- and 0.5-mm-diameter computed tomography and magnetic resonance images.
PubMed 文献 · Radiol Med · 2016-12-15

这项前瞻性研究纳入31例连续患者,在前列腺左侧置入0.35毫米直径标记、右侧置入0.5毫米直径标记(长度均为10毫米),于置入后3周行CT和MRI检查,由两名观察者评分。结果显示MRI显示前列腺轮廓显著优于CT,0.35毫米标记的CT伪影显著更少,而0.5毫米标记在MRI上的识别度显著更好。作者推荐使用0.5毫米直径标记。

要点

  • MRI显示前列腺轮廓显著优于CT。
  • 0.35毫米标记的CT伪影显著少于0.5毫米标记。
  • 0.5毫米标记在MRI上的识别度显著优于0.35毫米标记。

核心结论

  • 0.5毫米直径基准标记的可视化显著优于0.35毫米标记;虽然0.5毫米标记的CT伪影显著更重,但该伪影水平在临床实践中可耐受,作者据此推荐使用0.5毫米直径标记。

研究设计与样本

  • 前瞻性研究,纳入31例连续患者;前列腺左侧置入0.35毫米直径标记、右侧置入0.5毫米直径标记,标记长度均为10毫米;标记置入3周后行CT和MRI检查。

关键影像表现/征象

  • MRI显示前列腺轮廓显著优于CT。
  • 0.35毫米直径标记的CT伪影显著少于0.5毫米直径标记。
  • MRI上0.5毫米直径标记的识别度显著优于0.35毫米直径标记。

诊断标准与关键数值

  • 由两名观察者评估前列腺轮廓图像质量及标记可视化程度并评分。
  • MRI图像在T2*二维加权图像(T2*2D)与T2*三维加权图像(T2*3D)之间选择较优者。

临床应用与阅片要点

  • 作者推荐使用0.5毫米直径标记,理由是其在前列腺轮廓显示和MRI标记可视化方面表现更优。
  • 0.5毫米直径标记的CT伪影虽显著更重,但作者认为该伪影水平在临床实践中可耐受。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: When performing intensity-modulated radiotherapy for prostate cancer, a marker is inserted into the prostate to enable the recognition of its position using cone-beam computed tomography (CT). However, it is difficult to recognize the prostatic outline using CT alone. Magnetic resonance imaging (MRI) can depict the prostatic outline better than CT. In treatment plans using CT and MRI registration, various markers are used in institutions; however, the selection of an optimal marker size is difficult. Comparison of a different fiducial marker study was conducted using phantom, but no study in vivo was found. Therefore, we prospectively investigated the effects of different marker diameter sizes using CT and MR images.

METHODS: Thirty-one consecutive patients were enrolled in this study. CT and MRI were performed 3 weeks after marker placement. The 0.35-mm-diameter marker was placed on the left side of the prostate, and the 0.5-mm-diameter marker was placed on the right side. The length of each marker was 10 mm. The better MRI image was selected between those obtained using T2*-two-dimensional weighted image (T2*2D) and T2*-three-dimensional weighted image (T2*3D). Two observers evaluated and scored the prostatic outline image quality as well as visualized the prostatic markers using CT and MRI.

RESULTS: MRI was significantly superior to CT in depicting the prostatic outline. The CT artifacts were significantly lesser for the 0.35-mm-diameter marker than for the 0.5-mm-diameter marker. The degree of marker recognition using MRI was significantly better with the 0.5-mm-diameter marker.

CONCLUSION: The 0.5-mm-diameter fiducial marker had significantly better visualization than the 0.35-mm-diameter marker. While CT artifacts were significantly worse with the 0.5-mm-diameter marker, the artifact level was tolerable for clinical practice. Therefore, we recommend the 0.5-mm-diameter diameter marker in terms of prostatic outline and marker visualization using MRI.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Tanaka O, Komeda H, Iida T, et al. Fiducial marker for prostate radiotherapy: comparison of 0.35- and 0.5-mm-diameter computed tomography and magnetic resonance images. Radiol Med. 2016. PMID: 27981486. doi:10.1007/s11547-016-0715-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。